Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Phase I Clinical Studies of Tumor Necrosis Factor in Patients with Advanced Cancer

    Tumor necrosis factor (TNF), a macrophage-derived polypeptide, was initially described by Carswell and coworkers at Sloan-Kettering as the agent that produced hemorrhagic necrosis of certain transplanted sarco...

    A. A. Jakubowski, J. L. Gabrilove in Cytokines in Hemopoiesis, Oncology, and AI… (1990)

  2. No Access

    Article

    Chemotherapy of non-small cell lung cancer: Clinical trials at the Memorial Sloan-Kettering Cancer Center

    Bronchogenic carcinoma is one of the most difficult and pressing problems in cancer therapy. Overall survival of 799 primary cases at Memorial Sloan-Kettering Cancer Center was 7.8%, reflecting the advanced na.....

    R. J. Gralla, R. E. Wittes, E. S. Casper, D. P. Kelsen in World Journal of Surgery (1981)